Bioinformatics: The quest for new drugs finds significant profits

NEW YORK--July 31, 2002-- Bioinformatics, a combination of information technology (IT) and biological sciences, is being recognized as a critical component of drug discovery by both pharmaceutical and pure IT companies.

"With the massive quantities of data now available to researchers, computers have become essential," says Technical Insights Analyst Katherine Austin. "However, having the data in the computer does not mean that it can be used in any meaningful way. The challenge for bioinformatics developers is to design platforms that can manage, retrieve, organize, compare, manipulate, and integrate data in a way that accelerates research, rather than acting as a bottleneck."

The discovery of new drugs means substantial profits, making bioinformatics a bright new field. Bioinformatics and molecular modeling technologies have the potential, within three to five years, to hugely decrease the risk, cost, and expertise required for the early stages of drug development--target selection and validation.

A significant application of bioinformatics is in silico discovery, which is the collection of data to substantiate targets and better the chances that a particular drug lead will be successful. This technology sorts and organizes data to enable scientists to identify potential drug targets, disease susceptibility, drug toxicity and efficacy, as well as individual responses to medication.

In addition, computer modeling of molecular structure can aid researchers in optimizing a potential drug lead, by allowing them to observe the effects of structural changes without expensive wet-lab experiments. If two or three targets result in marketable drugs, it will be a very profitable investment for pharmaceutical companies.

Success in the bioinformatics market depends on improved integration and interoperability among different software vendors, database providers, computer hardware, and in-house compilations. Developers need to focus

Contact: Julia Rowell
Technical Insights

Page: 1 2

Related biology news :

1. Potential for enhanced sequestration of carbon in soils supports evaluations
2. NSF announces six FIBR awards to tackle some of biologys most challenging questions
3. Two-month study of life in mid-Atlantic yields trove of species, new insights & questions
4. U of T research answers key question in biochemistry
5. Symposium to tackle questions of genetic engineering and biodiversity
6. Confidentiality of genetic databases questioned by Stanford researchers
7. Bacteria spill their guts to aid researchers in quest for new antibiotics
8. NAS requests nominations for outstanding scientists
9. Antibiotic resistance risk from triclosan questioned
10. IU and Purdue scientists to answer questions about Brood X periodical cicadas
11. K-State soil carbon sequestration research playing role in climate change efforts

Post Your Comments:

(Date:8/15/2017)... HAMPTON, Va. , Aug. 15 2017   ivWatch LLC ... effectiveness of intravenous (IV) therapy, today announced receipt of its ISO ... (QMS) developed by the International Organization for Standardization (ISO┬«). ... ivWatch Model 400 Continuous Monitoring device for ... "This ...
(Date:6/30/2017)... 2017 Today, American Trucking Associations announced ... face and eye tracking software, became the newest ... "Artificial intelligence and advanced sensing ... a driver,s attentiveness levels while on the road.  ... detect fatigue and prevent potential accidents, which could ...
(Date:6/14/2017)... (NYSE: IBM ) is introducing several innovative partner startups ... collaboration between startups and global businesses, taking place in ... nine startups will showcase the solutions they have built with ... France is one of the ... percent increase in the number of startups created between 2012 ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Surgical Wound Market with the addition of its newest module, US Hemostats & ... market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... a leading provider of patient support solutions, has announced the ... which will launch this week. The VMS CNEs will address ... enhance the patient care experience by delivering peer-to-peer education programs ... to help women who have been diagnosed and are being ... ...
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
Breaking Biology Technology:
Cached News: